GKOS
HealthcareGlaukos Corporation
Live · NYSE · May 9, Close
What's Moving GKOS Today?
No stock-specific AI insight has been generated for GKOS yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
GKOS News
20 articles- How The Glaukos (GKOS) Narrative Is Shifting With New Guidance And Product Ramp ExpectationsYahoo Finance·May 4, 2026
- Two Medical Stocks Skyrocket After Demolishing Views — And One Is About To Break OutYahoo Finance·Apr 30, 2026
- Glaukos Gains on Q1 Earnings Beat & Improved 2026 Revenue OutlookYahoo Finance·Apr 30, 2026
- Glaukos Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Glaukos Corp (GKOS) Q1 2026 Earnings Call Highlights: Record Sales Surge and Raised GuidanceYahoo Finance·Apr 30, 2026
- Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·Apr 30, 2026
- Glaukos Corporation Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- Glaukos (GKOS) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·Apr 29, 2026
- Glaukos Announces First Quarter 2026 Financial ResultsYahoo Finance·Apr 29, 2026
- Is ISRG's International Weakness a Temporary Drag or Structural Risk?Yahoo Finance·Apr 29, 2026
- 3 Stocks Estimated To Be Trading Up To 43% Below Intrinsic ValueYahoo Finance·Apr 28, 2026
- Ligand Pharmaceuticals And 2 Other Stocks That May Be Trading At An Estimated DiscountYahoo Finance·Apr 28, 2026
- April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair ValueYahoo Finance·Apr 27, 2026
- 3 Stocks That Might Be Undervalued By Up To 32.8%Yahoo Finance·Apr 27, 2026
- 3 Stocks That Might Be Undervalued By Up To 48.3% Offering A Possible DiscountYahoo Finance·Apr 24, 2026
- LSI Industries And 2 Other Stocks That May Be Priced Below Estimated ValueYahoo Finance·Apr 24, 2026
- Discover BioLife Solutions And 2 Other Stocks That May Be Priced Below Their Estimated ValueYahoo Finance·Apr 23, 2026
- Goosehead Insurance And 2 Other Stocks That May Be Undervalued By The MarketYahoo Finance·Apr 23, 2026
- 3 Stocks That May Be Undervalued By Up To 46.2%Yahoo Finance·Apr 22, 2026
- Alkami Technology And 2 Other Stocks That May Be Undervalued By InvestorsYahoo Finance·Apr 22, 2026
All 20 articles loaded
Price Data
Fundamentals
Trading
About Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.